Novo Nordisk’s oral diabetes drug reduces heart-related risks by 14 percent
- Posted on October 21, 2024
- By Financial Express
- 1 Views
Novo Nordisk’s oral diabetes drug reduces heart-related risks by 14 percent
Novo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the year.
